Light Mode
$3.62 ↑ +0.00 (+0.00%) Trading Up from the previous close of $3.62
-3.56 (-49.58%) / 6M
Momentum, market sentiment, and recent alerts
WVE reads not so good: price sits above one of the two key moving averages, the 12-month move is -55.0%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Wave Life Sciences, Inc. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It develops and commercializes a pipeline of RNA medicines across a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.